The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

This Aim Minnow Is Picked by the NHS to Boost Hospital Communication but the Share Price Doesn't Yet Seem to Show It

2020-08-04 08:14:25

Hello, Share Prompters. A medical venture I’ve invested in for years and which has usually disappointed is Feedback plc (FDBK). It always appears to me to have huge potential that doesn't seem to have been followed through. Perhaps the company needs more marketing skills. Any road up, it's just had some good news that the share price seems yet to have fully reflected...

Feedback (#FDBK) – £5.05m placing & up to £0.54m open offer at 1p per share

2020-06-15 07:55:39

Another Medical Pioneer Recruited in the Virus Fight Sees a Soaring Share Price...

2020-04-21 08:20:43

Hello, Share Tweakers. It’s with some unease that I suggest you take a look at today’s choice. That’s because Tom has said that he doesn't rate it. And only a fool disregards his astute analysis. But I am sometimes a momentum player, and the company I have in mind could turn out to be a short-term winner...

Feedback (#FDBK) – Bleepa NHS pilot study but considers TexRAD further clinical data required for US FDA submission – this process “put on hiatus”

2019-11-18 07:29:35

Feedback plc – I having warned it at best looking like discounted placing ahoy…

2019-08-12 13:58:47

Writing last week on Feedback plc (FDBK), I concluded with the combination of the noted financials, Bleepa still in development (i.e. very much yet to be “revolutionising clinical messaging”!) and a market cap of sub £5 million, meaning it at best looking like discounted placing ahoy, currently natch avoid / sell. Now “Proposed placing and subscription to raise £2m”…

Feedback (#FDBK) – as warned, discounted fundraising (£2m at 1.2p per share)

2019-08-12 07:57:34

Feedback plc – “working on completing a placing… in order to develop Bleepa”. It mean ‘in order to keep the lights on’?

2019-08-08 08:25:36

A “Statement re Online Commentary” from Feedback plc (FDBK) which “confirms that, in order to develop BleepaTM, the company's clinical messaging product, it is currently working on completing a placing of new shares”…

Feedback (#FDBK) – notes FY revenue growth; though only to £0.563m, reckons “exciting opportunity has arisen from the first phase of our strategic review”. Hmmm

2019-07-10 07:55:48

Feedback (#FDBK) – proposed £1.375m placing at 1.5p, a 12% discount

2018-10-25 06:59:59

Feedback (#FDBK) – keep-the-lights-on £0.44m raise at 1.25p per share

2018-03-28 23:36:34

Feedback - Oh dear, Malcolm appears to have contracted a nasty bout of Woodforditis

2018-02-27 01:45:42

To be clear, I don’t believe Malcolm has ripped off shareholders in an investment trust he manages by stuffing it full of unquoted stocks to save his bacon elsewhere; however, he does seem to have picked up a few of the “star fund manager’s” bad habits when it comes to a stock, namely Feedback (FDBK).

So Much Potential, So Little Share Value. A Buying Opportunity Here, Gang?

2018-02-15 01:22:32

Hello, Shares Lovelies. It’s time to revisit a favourite penny share of mine. Though it’s not exactly repaid my loyalty in the last year. Nevertheless, I feel that, given its potential and support in 40 countries, the present lowly share price is unfair.

Feedback May Pay Back if the CE Marks Keep Coming

2017-11-21 01:10:52

Hello, Share Purloiners. There was a welter of off-stage discussion at the last mouth-watering UK Investor Show on April 1st about Feedback (FDBK). It’s another of those AIM-listed medical pioneers, looking to develop new life-saving techniques.

Feedback (#FDBK) delays in getting CE mark, very woolly trading statement, all jam tomorrow (if then)

2017-05-17 23:25:26

Feedback's Shares Doubled Last Week And the Future Looks Bright

2017-04-06 00:20:07

Hello Share Bottlers. Yesterday I took a look at Avacta (AVCT). Now I bring to your notice another medical pioneer, Feedback (FDBK).

Tom No Likey This Medical Pioneer - But I Do

2016-12-21 01:10:06

Hello Share Rattlers. Quite a few of my friends face a grim Christmas. They are undergoing radio and chemo treatment for cancer. Is it me, or is the number of cases growing even faster than normal?

Feedback (#FDBK) FY losses down but still burning cash, net current assets by now almost zero - PLACING AHOY

2016-10-18 23:37:18

My First-Hand Check on Medical Opportunities As I End Up in Hospital. Ref. Feedback, Avacter & Advanced Oncatherapy

2015-11-09 00:56:22

Hello Share Folk. I’m going to the hospital today to see about my prostate gland. I started the routine tests a few years ago and have been under the eye of a brilliant consultant ever since. There’s a lot of debate of whether we should have these tests done, as it causes a lot of anxiety and their reliability is not always that great. On the whole I would suggest you do have them done, if you’re of a certain age.  But what do I know?

Feedback (#FDBK) says it no longer sees any point in getting FDA approval fr TexRad

2015-10-07 23:19:35

Zak Mir's Bull Call Of The Day No.1:Feedback: 5p In View After Latest Gap Higher

2015-10-07 00:01:44

In some ways it feels as though the latest call on Feedback is somewhat late in the day, particularly in the wake of the initial spike for the shares to start this week.

Don’t You Hate the Small Profit-Takers? ref: Feedback.

2015-10-06 23:30:36

Hello Share Bunnies. There was some interesting share movements after all the good news came out for Feedback (FDBK), the minnow capitalised at a mere £5 million. 

Feedback and the Big Spanish Connection.

2015-10-05 23:44:14

Hello Share Thrashers. It’s not my custom to return to promising shares I’ve brought to your attention in the recent past. I normally wait at least six months or so - with only a few exceptions.

Zak Mir's Bull Call Of The Day No.1: Feedback: 3.5p Breakout Destination

2015-09-29 01:22:58

The present position for shares at Feedback (FDBK) looks to be well backed fundamentally – if you are a fan of rocket science. But as well as this we can bring in the art of technical analysis to attempt to divine where the share price may be heading near term.

The Chinese Appetite for British Medical Science Will Benefit Feedback Fans.

2015-09-18 15:39:38

Feedback (FDBK) is a company going places. And it’s just gone to another one. This is a compact firm, mostly owned by family and friends, with only a small proportion of ordinary share-shifters like us.

Feedback (#FDBK) - Is "delighted with positive results" from TexRAD CT texture analysis study

2015-07-19 23:42:42

Zak Mir's Great Request Show: Bowleven, Feedback, Union Jack Oil

2015-07-07 02:32:58

If you want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at Bowleven (BLVN), Feedback (FDBK), Union Jack Oil (UJO)

Feedback Shares Soften, but is that a Buying Opportunity?

2015-06-15 23:58:45

Hello Share Sappers. I beg your indulgence to return to Feedback (FDBK), the company which uses whizzo computers to help diagnose and monitor many types of cancer. As reported previously, this could be a topping investment. Though, as per usual, we should always add a cautionary note about medical pioneers.

I Love Feedback - It Might Make Me A Bit Better Off.

2015-06-04 00:38:37

Hello Share Swingers.  It seems ages ago that I first tipped Feedback (FDBK) the life science company. It was during all the excitement about another medical punt, Advanced Oncotherapy (AVO). I think I said something optimistic along the lines that Feedback could be another Advanced, which is a multi-bagger..

IS this Beauty the next Advanced Oncotherapy? – That’s What I Heard at the Big UK Investor Show.

2015-04-22 00:49:16

Hello Share Pickers. I told you I usually pick up some decent tips from the UK Investor Show which we were all treated to on Saturday. I’ve now had time to research a few of these diamonds and the first one I’ve bought is Feedback (FDBK).